Additional Value of Whole-Body Fluorodeoxyglucose Positron Emission Tomography in the Detection of Distant Metastases of Non–Small-Cell Lung Cancer
- 1 January 2003
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 4 (4) , 242-247
- https://doi.org/10.3816/clc.2003.n.005
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- High rate of detection of unsuspected distant metastases by PET in apparent Stage III non–small-cell lung cancer: implications for radical radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Non–Small-Cell Lung Cancer — Stalemate or Progress?New England Journal of Medicine, 2000
- Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission TomographyNew England Journal of Medicine, 2000
- Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancerThe Annals of Thoracic Surgery, 1999
- Detection of extrathoracic metastases by positron emission tomography in lung cancerThe Annals of Thoracic Surgery, 1998
- Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancerEuropean Respiratory Journal, 1997
- Revisions in the International System for Staging Lung CancerChest, 1997
- Distribution of distant metastases from newly diagnosed non-small cell lung cancerThe Annals of Thoracic Surgery, 1996
- Staging non—small cell lung cancer by whole-body positron emission tomographic imagingThe Annals of Thoracic Surgery, 1995
- Maximum Likelihood Reconstruction for Emission TomographyIEEE Transactions on Medical Imaging, 1982